Recent CPRX Stock Price | CPRX Stock Predictions | |
$23.25 | +30.28% |
$30.29 |
Recent CPRX Analyst Ratings Breakdown, Making CPRX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 7 | 7 | 7 | 7 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the CPRX stock predictions from the analysts covering Catalyst Pharmaceuticals Inc, we have collected all of the individual CPRX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 7 different analysts covering CPRX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CPRX stock predictions may vary widely, another useful metric to consider is the median CPRX stock prediction, which represents the price at which half of the analysts
made CPRX stock predictions that were higher and half made CPRX stock predictions that were lower. This makes for a different take on the CPRX stock predictions out there, as compared to average or mean.
And that median across all the individual CPRX stock predictions was: $30.0 as of 2024-11-01.
The very highest of the CPRX stock predictions for one year price target was $38.0, while the very lowest of the CPRX stock predictions in the analyst group was
$27.0 (with a standard deviation of $3.728). Get the latest Zacks research report on CPRX — FREE
Find out: CPRX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
EXTN Stock Predictions
UBA Stock Predictions
CYD Stock Predictions
FCAP Stock Predictions
EQT Stock Predictions
SJM Stock Predictions
NX Stock Predictions
TRHC Stock Predictions
KIM Stock Predictions
|
|
Strong Buy (4.00 out of 4) 95th percentile
(ranked higher than approx. 95% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |